Life Technologies reported $-20310000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Ardelyx USD -14400000 22.52M Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Cipla INR 15.25B 2.97B Jun/2025
Clal Biotechnology ILS -1738000 7.46M Dec/2022
Compugen USD -8430000 947K Jun/2025
CSL USD 1.98B 778M Dec/2024
Galapagos EUR -57027000 101.68M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
Grifols EUR 371.86M 54.83M Dec/2024
Life Technologies USD -20310000 4.49M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
United Therapeutics USD 276.9M 105.9M Jun/2025